Ozempic, Weight Loss

The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...
Novo has fired the most recent shot, asking the U.S. regulator to prevent compounders from manufacturing copycat versions of ...
Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating ...
The American Stroke Association has released new guidelines to lower your risk of stroke. Here’s what the organization ...
Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's ...
Weight loss can be a challenging journey, especially when seeking effective and accessible solutions. The rise in popularity ...